Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash, cash equivalents and restricted cash $ 151,632 $ 231,900
Short-term investments 240,104 234,178
Accounts receivable, net 18,173 15,414
Inventories, net 25,863 19,326
Prepaid expenses and other current assets 17,421 12,506
Total current assets 453,193 513,324
Non-current assets    
Other non-current assets 12,355 11,838
Property and equipment, net 4,183 4,418
Acquired intellectual property and other intangible assets, net 7,338 8,404
Right-of-use assets, net 5,079 5,383
Total assets 482,148 543,367
Current liabilities    
Accounts payable and accrued liabilities 32,380 34,947
Other current liabilities 1,293 4,640
Operating lease liabilities 953 1,059
Total current liabilities 34,626 40,646
Non-current liabilities    
Deferred compensation and other non-current liabilities 16,323 15,950
Operating lease liabilities 7,431 7,680
Total liabilities 58,380 64,276
Commitments and contingencies
SHAREHOLDER’S EQUITY    
Common shares - no par value, unlimited shares authorized, 141,892 and 141,600 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 1,180,884 1,177,051
Additional paid-in capital 74,004 59,014
Accumulated other comprehensive loss (1,853) (852)
Accumulated deficit (829,267) (756,122)
Total shareholders' equity 423,768 479,091
Total liabilities and shareholders’ equity $ 482,148 $ 543,367